Sony and Illumina Set to Change the Way Doctors Identify and Treat Cancer (ILMN, SNE)

In a story first reported by Nikkei and updated recently by Le Monde , Sony Corp. (NYSE: SNE ) and U.S. genome sequencing equipment maker Illumina Inc. (NASDAQ: ILMN ) plan to launch a human genome analysis project in October. The project will involve the study and analysis of